<sup>68</sup>Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease

<sup>68</sup>Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease

Two patients with a history of multiple myeloma experienced a recurrence of the disease.<sup>18</sup>F-FDG PET/CT revealed prominent extramedullary disease as well as multi-foci in the bone marrow, both with increased FDG uptake. However, on <sup>68</sup>Ga-Pentixafor PET/CT,...

Full description

Bibliographic Details
Main Authors:	Qingqing Pan, Yaping Luo, Xinxin Cao, Jian Li, Fang Li
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Diagnostics
Subjects:	multiple myeloma extramedullary disease <sup>68</sup>Ga-Pentixafor PET/CT
Online Access:	https://www.mdpi.com/2075-4418/13/5/871

Similar Items

<sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-Pentixafor PET/CT in a Patient with Castleman Disease of the Retroperitoneum
by: Rui Zuo, et al.
Published: (2024-02-01)

Bing–Neel Syndrome and Coexisting Pituitary Macroadenoma in a Patient with Waldenström Macroglobulinemia Revealed by <sup>18</sup>F-FDG and <sup>68</sup>Ga-Pentixafor PET/CT
by: Qingqing Pan, et al.
Published: (2023-04-01)

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI
by: Xia Lu, et al.
Published: (2022-07-01)

[<sup>68</sup>Ga]Ga-Pentixafor and Sodium [<sup>18</sup>F]Fluoride PET Can Non-Invasively Identify and Monitor the Dynamics of Orthodontic Tooth Movement in Mouse Model
by: Rogerio B. Craveiro, et al.
Published: (2022-09-01)

Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [<sup>68</sup>Ga] Pentixafor Internalization in Neuroendocrine Tumor Cells
by: Alexander Weich, et al.
Published: (2021-02-01)

[<sup>68</sup>Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with <sup>18</sup>F[FDG] PET Imaging
by: Ismaheel O. Lawal, et al.
Published: (2020-12-01)

Analysis of Pros and Cons in Using [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
by: Costantina Maisto, et al.
Published: (2022-06-01)

New Targets for PET Imaging of Myeloma
by: Mona-Elisabeth Revheim, et al.
Published: (2021-12-01)

A Simple Kit for the Good-Manufacturing-Practice Production of [<sup>68</sup>Ga]Ga-EDTA
by: Monika Skulska, et al.
Published: (2023-08-01)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021-04-01)

On the Optimization of the Protocol for Automated Radiosyntheses of [68Ga]Ga-Pentixafor, [68Ga]Ga-FAPI-4 and [68Ga]Ga-DOTATATE in a Modular-Lab Standard
by: Sreeja Menon, et al.
Published: (2024-07-01)

Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
by: Rahul Viswanathan, et al.
Published: (2024-02-01)

Current Status of <sup>68</sup>Ga-Pentixafor in Solid Tumours
by: Bawinile Hadebe, et al.
Published: (2022-09-01)

68Ga-pentixafor PET/CT in guiding surgical management of primary aldosteronism
by: Guoyang Zheng, et al.
Published: (2025-03-01)

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023-11-01)

Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
by: Vusani Mandiwana, et al.
Published: (2021-04-01)

Automated synthesis and quality control of [68Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging
by: Thomas Daniel, et al.
Published: (2023-02-01)

Imaging findings and clinical relevance of 68Ga-Pentixafor PET in atherosclerosis: a systematic review
by: Min Wang, et al.
Published: (2023-10-01)

TiO<sub>2</sub> Decorated Low-Molecular Chitosan a Microsized Adsorbent for a <sup>68</sup>Ge/<sup>68</sup>Ga Generator System
by: Jun-Young Lee, et al.
Published: (2021-05-01)

Different Uptake of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG in Lymphadenopathy Caused by Angioimmunoblastic T-Cell Lymphoma in a Patient with Colon Cancer
by: Meiqi Wu, et al.
Published: (2022-09-01)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01)

Comparison of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI in Spindle Cell Rhabdomyosarcoma
by: Zhihui Shen, et al.
Published: (2023-09-01)

Rapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [<sup>68</sup>Ga]Ga-PSMA-11 in a Droplet Reactor
by: Yingqing Lu, et al.
Published: (2024-09-01)

<sup>68</sup>Ga-PSMA PET/CT in Recurrent Prostate Cancer after Radical Prostatectomy Using PSMA-RADS Version 2.0
by: Gabriele Masselli, et al.
Published: (2024-06-01)

<sup>68</sup>Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [<sup>68</sup>Ga]Ga-RM2
by: Adrien Chastel, et al.
Published: (2021-07-01)

Fully Automated Macro- and Microfluidic Production of [<sup>68</sup>Ga]Ga-Citrate on mAIO<sup>®</sup> and iMiDEV<sup>TM</sup> Modules
by: Olga Ovdiichuk, et al.
Published: (2022-02-01)

Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by <sup>68</sup>Ga-PSMA PET/CT
by: Mads T. Christensen, et al.
Published: (2022-01-01)

Optimized <sup>68</sup>Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022-08-01)

On the automated radiosynthesis of pharmaceutical grade [68Ga]Ga-Pentixafor, its pre-clinical evaluation, clinical application and radiation dosimetry aspects
by: Sreeja Raj Menon, et al.
Published: (2025-02-01)

Clinical value of 68Ga-pentixafor PET/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study
by: Rui Zuo, et al.
Published: (2024-07-01)

Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023-03-01)

<sup>68</sup>Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
by: Henri Baudhuin, et al.
Published: (2021-05-01)

68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism
by: MengDan Li, et al.
Published: (2025-01-01)

A comparison of the performance of 68Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism
by: Xuan Yin, et al.
Published: (2024-02-01)

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
by: Alexander Weich, et al.
Published: (2021-03-01)

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A <sup>68</sup>Ga-FAPI-04 PET/CT Imaging Study
by: Jingnan Wang, et al.
Published: (2023-04-01)

Prevalence of Brain Incidental Lesions Detected by <sup>68</sup>Ga-DOTA Peptides PET/CT
by: Domenico Albano, et al.
Published: (2022-07-01)

Relevance of Volumetric Parameters Applied to [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
by: Luca Urso, et al.
Published: (2023-02-01)

A Specific HPLC Method to Determine Residual HEPES in [<sup>68</sup>Ga]Ga-Radiopharmaceuticals: Development and Validation
by: Silvia Migliari, et al.
Published: (2022-07-01)

Automated Synthesis of [<sup>68</sup>Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
by: Elisabeth Plhak, et al.
Published: (2023-08-01)